母牛分枝杆菌菌苗辅助治疗初治菌阳肺结核的临床分析

中国防痨杂志 ›› 2004, Vol. 26 ›› Issue (2): 98-100.

母牛分枝杆菌菌苗辅助治疗初治菌阳肺结核的临床分析

高卫红¹；高春荣¹；陈磊¹；

1.浙江省宁波市第四医院宁波 315031；

出版日期:2004-02-10 发布日期:2004-11-03

The clinic analysis on the effect of Mycobacterium vaccae vaccine to treatment outcome of new bacteriological positive pulmonary tu berculosis cases

Gao Weihong,Gao Chunrong,Chen Lei.

The fourth Hospital of Ningb o,Zhejiang 315031

Online:2004-02-10 Published:2004-11-03

摘要/Abstract

摘要： 目的　观察和评价母牛分枝杆菌菌苗 (微卡菌苗)在初治菌阳肺结核治疗中的作用。方法采用随机配对分组法,分微卡菌苗治疗组 (A组,84例 )和对照组 (B组,84例 )。 2组化疗方案均为2HRZE 4HR,A组加用微卡菌苗治疗 2月,B组不用微卡菌苗。结果 A组第 1月涂片阴转率36.9%,培养阴转率 47.6%；第 2月涂片阴转率 79.8%,培养阴转率 85.7%。B组第 1月涂片阴转率19.0%,培养阴转率 17.9%；第 2月涂片阴转率 53.8%,培养阴转率 67.9%。前 2月痰菌阴转率A组显著高于B组 (P＜0.01 )。疗程满 6个月后A组涂片阴转率 98.8%,培养阴转率 97.6%；B组涂片阴转率 96.4%,培养阴转率 97.6%。A组和B组治疗 6个月痰菌阴转率无显著性差异 (P＞0.05)。病灶吸收好转及空洞缩小关闭速度,A组优于B组。A组的细胞免疫功能显著改善。随访A组和B组的细菌学复发率分别为 1.3%和 2.6% (P＞0.05)。结论微卡菌苗能改善初治菌阳肺结核患者的细胞免疫功能,加快痰菌阴转、病灶吸收及空洞缩小关闭的速度,不良反应少且轻微。微卡菌苗可用作初治菌阳肺结核的免疫治疗。

关键词: 结核,肺, 分枝杆菌,母牛, 免疫治疗

Abstract: Objective To evaluate the effect and safety of Mycobacterium vaccae vaccine (M.vaccae vaccine) to treatment outcome of new pulmonary tuberculosis cases.Methods 168 new bacteriological positive pulmonary tuberculosis cases were divided into immunotherapy (A,84 cases)group and control (B,84 cases) group randomly.The cases in two groups were treated by the same chemotherapy regimen of 2HRZE/4HR.The group A were treated immunotherapy with M.vaccae vaccine for 2 months.There was no immonotherapy with M.vac cae in group B.Results The sputum smear negative conversion rates in group A 1,2 and 6 months after treatment were 36.9%, 79.8% and 97.6% respec tively;those in group B were 19.0%,53.8% and 96.4% respectively.The sputum culture-negative conversion rates in group A the end of 1,2 and 6 months treatment were 47.6%,85.7% and 98.8% respectively;those in group B were 17.9% ,67.9% and 97.6% respectively.The sputum negative conversion rates of group A were signi ficantly higher than those of group B after 1 and 2 months treatment(P＜0.01 ).But there were no statistically significant differences between the two groups at the end of 6 months after treatment (P＞0.05).Compared with group B,the effect on improving of X ray manifestation in group A were better (P＜0.01).The side effects of M.vaccae vaccine were rare and slight.The bacterio logical relapse rates in group A,B were 1.3%,2.6% respectively(P＞0.05). Conclusion M.vaccae vaccine is helpful on speeding negative conversion,improving of X ray monifestation for new bacteriological positive pul monary tuberculosis.

Key words: Tuberculosis,pulmonary, Mycobacterium vaccae, I mmunotherapy

高卫红,高春荣,陈磊,. 母牛分枝杆菌菌苗辅助治疗初治菌阳肺结核的临床分析[J]. 中国防痨杂志, 2004, 26(2): 98-100.

Gao Weihong,Gao Chunrong,Chen Lei.. The clinic analysis on the effect of Mycobacterium vaccae vaccine to treatment outcome of new bacteriological positive pulmonary tu berculosis cases[J]. Chinese Journal of Antituberculosis, 2004, 26(2): 98-100.

[1]	雷建平,彭燕,熊国亮,张玉珍,周军,刘翼军1,邢娟娟,李光明,雷铭宙,袁小亮,涂荣耀,涂少华,. 不同时期卡介苗免疫治疗对结核病大鼠疗效和CD4⁺CD8⁺双阳(DP)T细胞的影响[J]. 中国防痨杂志, 2006, 28(6): 404-407.
[2]	袁保东,王卫华,段琼红,张炎林,陆兰英. 耐多药肺结核患者生命质量的评价[J]. 中国防痨杂志, 2006, 28(3): 139-142.
[3]	冀澍雨,刘瑾,颜鸿飞,张继兴,苏孟,耿凤英,. 化学药物联合免疫调节剂治疗复治肺结核的疗效观察[J]. 中国防痨杂志, 2002, 24(3): 137-139.
[4]	卢水华,汪自然,王汉香,熊昌富,王彦君,朱庭菊,顾晓洪,徐学文,. 胸腔内灌注母牛分支杆菌疫苗治疗癌性胸液[J]. 中国防痨杂志, 2001, 23(3): 184-186.